ACVA vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ACVA exhibits a Piotroski F-Score of 5/9, indicating stable financial health, but lacks an Altman Z-Score, limiting distress risk assessment. The company shows strong revenue growth (16.5% YoY) and impressive earnings surprise trends, yet remains unprofitable with negative profit and return metrics. Valuation appears stretched on a forward P/E of 34.17 despite weak fundamentals, while insider selling and mixed technicals suggest caution. Analysts recommend a 'buy' with a $10.71 target, implying upside, but fundamentals do not robustly support this optimism.
Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.
Compare Another Pair
Related Comparisons
ACVA vs TSLA: Head-to-Head Comparison
This page compares ACV Auctions Inc. (ACVA) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.